Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.27%779.85B | -4.96%3.24T | -3.55%747.95B | 6.54%3.4T | 1.36%863.1B | 6.22%903.55B | 7.13%862.51B | 12.68%775.47B | 27.09%3.2T | 16.57%851.55B |
| Cost of revenue | 8.19%623.58B | -5.01%2.57T | -6.84%576.36B | 4.18%2.71T | -1.36%696.11B | 3.43%702.96B | 5.32%691.38B | 10.76%618.66B | 26.47%2.6T | 15.49%705.69B |
| Gross profit | -8.93%156.28B | -4.78%662.3B | 9.43%171.6B | 16.86%695.52B | 14.49%166.99B | 17.31%200.6B | 15.08%171.13B | 20.96%156.8B | 29.90%595.19B | 22.12%145.86B |
| Operating expense | -100.17%-163M | 4.58%432.84B | 7.36%94.68B | 21.15%413.88B | 54.01%138.91B | 5.77%90.23B | 5.76%96.54B | 17.82%88.2B | 26.07%341.64B | 11.55%90.19B |
| Staff costs | ---- | ---- | ---- | 8.09%146.25B | ---- | ---- | ---- | ---- | 15.24%135.3B | ---- |
| Selling and administrative expenses | ---- | 8.09%430.27B | ---- | 341.41%398.05B | ---- | ---- | ---- | ---- | 40.26%90.18B | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -5.75%84.99B | ---- | ---- | ---- | ---- | 40.26%90.18B | ---- |
| -General and administrative expense | ---- | 8.09%430.27B | ---- | --398.05B | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | ---- | ---- | ---- | 5.53%21.99B | ---- | ---- | ---- | ---- | -2.79%20.84B | ---- |
| -Depreciation | ---- | ---- | ---- | 5.53%21.99B | ---- | ---- | ---- | ---- | -2.79%20.84B | ---- |
| Other operating expenses | --1.65B | -64.22%8.83B | ---- | -74.10%24.69B | ---- | ---- | ---- | ---- | 40.50%95.33B | ---- |
| Total other operating income | --1.81B | -29.36%6.26B | ---- | --8.86B | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 103.40%156.44B | -18.53%229.46B | 12.11%76.91B | 11.08%281.64B | -49.56%28.08B | 28.80%110.37B | 29.90%74.59B | 25.26%68.61B | 35.44%253.55B | 44.26%55.67B |
| Net non-operating interest income (expenses) | 98.62%4.19B | -52.61%6.33B | 75.81%2.11B | 294.80%13.36B | 647.85%9.22B | 55.70%1.67B | 86.03%1.28B | 203.54%1.2B | 180.91%3.39B | 287.74%1.23B |
| Non-operating interest income | 102.80%6.23B | -9.75%18.84B | 51.28%3.07B | 271.90%20.87B | 671.45%13.7B | 76.20%2.72B | 86.10%2.42B | 104.64%2.03B | 68.28%5.61B | 107.96%1.78B |
| Non-operating interest expense | 111.94%2.04B | 66.55%12.5B | 15.88%963M | 237.09%7.51B | 725.05%4.48B | 122.67%1.05B | 86.18%1.15B | 39.20%831M | 4.55%2.23B | 1.31%543M |
| Net investment income | -22.94%112.5B | -18.43%3.05B | 4,647.64%145.99B | 6,625.68%141.17B | 69.40%-2.06B | -42.99%3.13B | 69.72%3.74B | -72.07%3.08B | -60.92%2.1B | |
| Gain(Loss) on financial instruments designated as cash flow hedges | 9.31%-1.55B | -70.57%-539M | -79.12%-1.71B | -162.67%-570M | -76.12%-509M | -47.87%-312M | -33.90%-316M | -282.73%-953M | -233.85%-217M | |
| Gain(Loss) on derecognition of available-for-sale financial assets | 91.04%1.45B | -169.13%-5.96B | -75.07%759M | 237.59%2.3B | -99.85%2M | -44.66%674M | -1,251.22%-2.22B | 238.66%3.05B | 123.68%681M | |
| Income from associates and other participating interests | 116.13%2.8B | 300.22%9.17B | 26.19%1.3B | -60.26%2.29B | -440.62%-5.08B | 172.19%2.47B | 55.14%3.88B | 18.59%1.03B | -40.05%5.77B | -67.94%1.49B |
| Special income (charges) | 311.92%2.33B | -485.81%-867M | 64.66%-1.1B | 114.79%315M | -111.03%-861M | -38.70%-405M | 47.14%-148M | -56.75%-3.11B | -331.17%-2.13B | |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---169M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | ---- | -366.91%-2.93B | 224.32%480M | -61.54%1.1B | -86.10%296M | 32.98%250M | 38.49%403M | -39.09%148M | 73.80%2.85B | 386.30%2.13B |
| Less:Write off | ---- | 29,850.00%599M | --556M | -99.22%2M | ---611M | 177.73%611M | 100.00%2M | --0 | -24.78%258M | --0 |
| Other non-operating income (expenses) | -56.22%-3.07B | -43.93%360M | -138.55%-1.96B | -387.96%-3.45B | -92.48%315M | -33.75%526M | -20.94%642M | 1,700.63%5.09B | -116.56%-706M | |
| Income before tax | -15.91%64.21B | -17.60%244.96B | 5.26%76.36B | 10.17%297.3B | -48.36%30.01B | 29.90%111.39B | 23.28%83.36B | 24.28%72.54B | 32.09%269.84B | 28.67%58.11B |
| Income tax | -18.36%13.89B | -22.14%64.04B | 4.57%17.01B | 12.31%82.25B | -32.67%13.41B | 24.37%25.66B | 29.82%26.91B | 36.02%16.27B | 53.99%73.24B | 34.02%19.92B |
| Net income | -15.21%50.32B | -15.87%180.92B | 5.47%59.35B | 9.38%215.04B | -56.54%16.6B | 31.66%85.73B | 20.39%56.44B | 21.26%56.27B | 25.45%196.6B | 26.05%38.2B |
| Net income continuous operations | -15.21%50.32B | -15.87%180.92B | 5.47%59.35B | 9.38%215.04B | -56.54%16.6B | 31.65%85.73B | 20.39%56.45B | 21.26%56.27B | 25.45%196.6B | 26.05%38.2B |
| Noncontrolling interests | -28.40%8.9B | -11.27%40.86B | 10.74%12.44B | 2.65%46.05B | -42.87%7.03B | 17.54%14.41B | 34.60%13.38B | 8.44%11.23B | 46.94%44.86B | 40.14%12.3B |
| Net income attributable to the company | -11.71%41.42B | -17.12%140.06B | 4.15%46.91B | 11.37%169B | -63.03%9.57B | 34.93%71.32B | 16.57%43.07B | 24.94%45.04B | 20.25%151.74B | 20.29%25.89B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -11.71%41.42B | -17.12%140.06B | 4.15%46.91B | 11.37%169B | -63.03%9.57B | 34.93%71.32B | 16.57%43.07B | 24.94%45.04B | 20.25%151.74B | 20.29%25.89B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.12%58.18 | -13.37%190.78 | 0.00%58.11 | 12.50%220.22 | -58.35%13.91 | 35.89%92.65 | 16.55%55.55 | 24.94%58.11 | 20.19%195.75 | 20.32%33.4 |
| Diluted earnings per share | 0.09%58.16 | -13.28%190.75 | 0.00%58.11 | 12.36%219.95 | -61.72%12.7851 | 35.89%92.65 | 16.55%55.55 | 24.94%58.11 | 20.19%195.75 | 20.32%33.4 |
| Dividend per share | 0 | 0.00%92 | 0 | 16.46%92 | 13.95%49 | 0 | 19.44%43 | 0 | 19.70%79 | 16.22%43 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |